Latest News about FATE
Recent news which mentions FATE
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
January 24, 2023
From Benzinga
5 Health Care Stocks That Are Diving - And May Rally
January 19, 2023
From Benzinga
Over $10 Million Bet On DiamondHead Holdings? Check Out These 4 Stocks Insiders Are Buying
January 17, 2023
From Benzinga
Top 5 Health Care Stocks That May Surge
January 10, 2023
From Benzinga
From InvestorPlace
Dow Jumps 700 Points; S&P 500 Rises Over 2%
January 06, 2023
From Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 06, 2023
From Benzinga
Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge
January 06, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 06, 2023
From Benzinga
Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday
January 06, 2023
From Benzinga
Why Is Fate Therapeutics (FATE) Stock Down 62% Today?
January 06, 2023
From InvestorPlace
Tesla Falls Again, but This Nasdaq Stock Is Truly Plunging
January 06, 2023
From Motley Fool
Fate Therapeutics Ends Collaboration Deal With Janssen, Cuts Staff
January 06, 2023
From Benzinga
Dow Rises Over 300 Points; US Adds 223,000 Jobs In December
January 06, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 06, 2023
From Benzinga
Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday
January 06, 2023
From Benzinga
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
January 06, 2023
From Benzinga
From InvestorPlace
What 6 Analyst Ratings Have To Say About Fate Therapeutics
January 05, 2023
Tickers
FATE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
From Benzinga